Target intelligence / Profile preview

DNAAF4-CCPG1 readthrough (non-protein coding) (DNAAF4-CCPG1)

Target
DNAAF4-CCPG1
Molecular classification
Other (readthrough, non-coding RNA, lncRNA[1])
01

Overview

The DNAAF4-CCPG1 readthrough locus represents a naturally occurring transcriptional readthrough between two neighboring genes on chromosome 15: *Dyslexia susceptibility 1 candidate 1* (DYX1C1, also known as DNAAF4) and *Cell cycle progression 1* (CCPG1). This transcript is classified as a candidate for *nonsense-mediated mRNA decay (NMD)*, which means it is rapidly degraded in cells and is unlikely to yield a functional protein product. It is considered a non-coding RNA of the long non-coding RNA (lncRNA) class and is not a therapeutic target or functional receptor, enzyme, or transporter. Diseases associated with this region are due to mutations in the underlying functional neighboring genes (DYX1C1/DNAAF4—for ciliary dyskinesia and reading disability/dyslexia, CCPG1—for autophagy/ER-phagy), but not the readthrough transcript itself[1]. This target is not a functional molecule itself but an annotation reflecting an intergenic readthrough transcript that is subjected to decay, with no known protein product or direct role in drug targeting, signaling, or disease mechanism[1]. Any biological/disease relevance is due to defects in the component genes, not the noncoding readthrough.

Other names
DYX1C1-CCPG1DYX1C1-CCPG1 readthrough (NMD candidate)DYX1C1-CCPG1 readthrough (non-protein coding)
02

Biological functions

Other (non-coding RNA, likely no canonical biological function since it is targeted for nonsense-mediated mRNA decay and unlikely to encode a protein[1])
03

Disease associations

Other (the locus is associated with neighboring gene disorders such as ciliary dyskinesia and dyslexia[1])

Beyond the preview

Go deeper on DNAAF4-CCPG1 readthrough (non-protein coding) (DNAAF4-CCPG1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNAAF4-CCPG1 readthrough (non-protein coding) (DNAAF4-CCPG1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call